Potassium channels as drug targets for therapeutic intervention in respiratory diseases

Bibliography

• Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev 2008;8(3):218-30
   Google Scholar
• Joos GF, O'Connor B, Anderson SD, et al. Indirect airway challenges. Eur Respir J 2003;21(6):1050-68
   PubMed Web of Science ®Google Scholar
• Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368(9537):780-93
   PubMed Web of Science ®Google Scholar
• MacNee W. Oxidants and COPD. Curr Drug Targets 2005;4(6):627-41
   Google Scholar
• Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med 2005;26(2):142-53
   PubMed Web of Science ®Google Scholar
• Jeffery P. Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 1999;29(Suppl 2):14-26
   PubMed Web of Science ®Google Scholar
• The Global Initiative for Chronic Obstructive Lung Disease [cited 01 July 2008]; Available from: http://www.goldcopd.org
   Google Scholar
• Culpitt SV, Maziak W, Loukidis S, et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Res Crit Care Med 1999;160(5 Pt 1):1635-1
   PubMed Web of Science ®Google Scholar
• Loppow D, Schleiss MB, Kanniess F, et al. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 2001;95(2):115-21
   PubMed Web of Science ®Google Scholar
• Shieh CC, Coghlan M, Sullivan JP, et al. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 2000;52(4):557-94
   PubMed Web of Science ®Google Scholar
• Lawson K, McKay NG. Modulation of potassium channels as a therapeutic approach. Curr Pharm Des 2006;12(4):459-70
   PubMed Web of Science ®Google Scholar
• Garcia ML, Kaczorowski GJ. Potassium channels as targets for therapeutic intervention. Sci Signal STKE 2005;2005(302):pe46
   PubMedGoogle Scholar
• Yost CS. Potassium channels: basic aspects, functional roles, and medical significance. Anesthesiology 1999;90(4):1186-203
   PubMedGoogle Scholar
• Alexander S, Peters, JA. Receptor and ion channel nomenclature supplement. Trends Pharmacol Sci 2000;21:106-12
   Google Scholar
• Pelaia G, Gallelli L, Vatrella A, et al. Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. Life Sci 2002;70(9):977-90
   PubMed Web of Science ®Google Scholar
• Black JL, Barnes PJ. Potassium channels and airway function: new therapeutic prospects. Thorax 1990;45(3):213-8
   PubMed Web of Science ®Google Scholar
• Fozard JR, Manley PW. Potassium channel openers: agents for the treatment of airway hyperreactivity. In: Hansel TT, Barnes PJ, Editors, New drugs for asthma, allergy and COPD. Karger: Basel, Prog Respir Res 2001;31:77-80
   Google Scholar
• Poggioli R, Benelli A, Arletti R, et al. Antitussive effect of K+ channel openers. Eur J Pharmacol 1999;371(1):39-42
   PubMed Web of Science ®Google Scholar
• Baird A, Hamilton T, Richards D, et al. Cromakalim, a potassium channel activator, inhibits histamine induced bronchoconstriction in healthy volunteers. Br J Clin Pharmacol 1988;24:114P
   Google Scholar
• Williams AJ, Lee TH, Cochrane GM, et al. Attenuation of nocturnal asthma by cromakalim. Lancet 1990;336(8711):334-6
   PubMedGoogle Scholar
• Shepherd MC, Duffy SM, Harris T, et al. KCa3.1 Ca2+ activated K+ channels regulate human airway smooth muscle proliferation. Am J Res cell Mol Boil 2007;37(5):525-31
   PubMed Web of Science ®Google Scholar
• Fox AJ, Barnes PJ, Venkatesan P, et al. Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest 1997;99(3):513-9
   PubMed Web of Science ®Google Scholar
• Morita K, Onodera K, Kamei J. Inhaled pinacidil, an ATP-sensitive K+ channel opener, and moguisteine have potent antitussive effects in guinea pigs. Jpn J Pharmacol 2002;89(2):171-5
   PubMedGoogle Scholar
• Sutovska M, Nosalova G, Franova S. The role of potassium ion channels in cough and other reflexes of the airways. J Physiol Pharmacol 2007;58(Suppl 5)(Pt 2):673-83
   PubMed Web of Science ®Google Scholar
• Ramnarine SI, Liu YC, Rogers DF. Neuroregulation of mucus secretion by opioid receptors and K(ATP) and BK(Ca) channels in ferret trachea in vitro. Br J Pharmacol 1998;123(8):1631-8
   PubMed Web of Science ®Google Scholar
• Liu YC, Patel HJ, Khawaja AM, et al. Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release. Br J Pharmacol 1999;126(1):147-58
   PubMedGoogle Scholar
• Redington AE, Polosa R, Walls AF, et al. Role of mast cells and basophils in asthma. Chem Immunol 1995;62:22-59
   PubMedGoogle Scholar
• Mark Duffy S, Berger P, Cruse G, et al. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells. J Allergy Clin Immunol 2004;114(1):66-72
   PubMedGoogle Scholar
• Cruse G, Duffy SM, Brightling CE, Bradding P. Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax 2006;61(10):880-5
   PubMedGoogle Scholar
• Fanger CM, Rauer H, Neben AL, et al. Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J Biol Chem 2001;276(15):12249-56
   PubMed Web of Science ®Google Scholar
• Ghanshani S, Wulff H, Miller MJ, et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 2000;275(47):37137-49
   PubMed Web of Science ®Google Scholar
• Jensen BS, Odum N, Jorgensen NK, et al. Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(19):10917-21
   Google Scholar
• Saito M, Hisatome I, Nakajima S, et al. Possible mechanism of oxygen radical production by human eosinophils mediated by K+ channel activation. Eur J Pharmacol 1995;291(2):217-9
   PubMedGoogle Scholar
• Bankers-Fulbright JL, Kephart GM, Loegering DA, et al. Sulfonylureas inhibit cytokine-induced eosinophil survival and activation. J Immunol 1998;160(11):5546-53
   PubMedGoogle Scholar
• Schwingshackl A, Moqbel R, Duszyk M. Nitric oxide activates ATP-dependent K+ channels in human eosinophils. J Leukoc Boil 2002;71(5):807-12
   PubMedGoogle Scholar
• Da Silva-Santos JE, Santos-Silva MC, Cunha Fde Q, et al. The role of ATP-sensitive potassium channels in neutrophil migration and plasma exudation. J Pharmacol Exp Ther 2002;300(3):946-51
   PubMedGoogle Scholar
• Maruyama N, Kakuta Y, Yamauchi K, et al. Quinine inhibits production of tumor necrosis factor-alpha from human alveolar macrophages. Am J Res Cell Mol Boil 1994;10(5):514-20
   PubMedGoogle Scholar
• Blunck R, Scheel O, Muller M, et al. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J Immunol 2001;166(2):1009-15
   PubMed Web of Science ®Google Scholar
• Priest BT, Swensen AM, McManus OB. Automated electrophysiology in drug discovery. Curr Pharm Des 2007;13(23):2325-37
   PubMed Web of Science ®Google Scholar
• Furukawa K, Itoh T, Kajiwara M, et al. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J pharmacol Exp Ther 1981;218(1):248-59
   PubMedGoogle Scholar
• Itoh T, Furukawa K, Kajiwara M, et al. Effects of 2-nicotinamidoethyl nitrate on smooth muscle cells and on adrenergic transmission in the guinea-pig and porcine mesenteric arteries. J Pharmacol Exp Ther 1981;218(1):260-70
   PubMedGoogle Scholar
• Hamilton TC, Weir SW, Weston AH. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 1986;88(1):103-11
   PubMed Web of Science ®Google Scholar
• Weir SW, Weston AH. Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol 1986;88(1):113-120
   PubMedGoogle Scholar
• Cook NS, Quast U, Hof RP, et al. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915. J Cardiovasc Pharmacol 1988;11(1):90-9
   PubMed Web of Science ®Google Scholar
• Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 1993;33:597-637
   PubMed Web of Science ®Google Scholar
• Mannhold R. Structure-activity relationships of K(ATP) channel openers. Curr Top Med Chem 2006;6(10):1031-47
   PubMed Web of Science ®Google Scholar
• Cook NS, Chapman ID. Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma. Cardiovascular drugs and therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy 1993;7(Suppl 3):555-63
   Google Scholar
• Buchheit KH, Fozard JR. KATP channel openers for the treatment of airways hyperreactivity. Pulm Pharmacol Ther 1999;12(2):103-5
   PubMed Web of Science ®Google Scholar
• Prasad MR, Bahekar RH, Rao AR. Recent perspectives in the design of antiasthmatic agents. Die Pharmazie 2000;55(7):475-82
   PubMedGoogle Scholar
• Allen SL, Boyle JP, Cortijo J, et al. Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol 1986;89(2):395-405
   PubMedGoogle Scholar
• Kidney JC, Fuller RW, Worsdell YM, et al. Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol. Thorax 1993;48(2):130-3
   PubMedGoogle Scholar
• Buckle DRE, Drake S, Pinto, et al. Synthesis of BRL 55834, a novel, potent airways-selective potassium channel activator. Bioorg Med Chem Lett 1992;2(9):1161-4
   Web of Science ®Google Scholar
• Bowring NE, Arch JR, Buckle DR, et al. Comparison of the airways relaxant and hypotensive potencies of the potassium channel activators BRL 55834 and levcromakalim (BRL 38227) in vivo in guinea-pigs and rats. Br J Pharmacol 1993;109(4):1133-9
   PubMedGoogle Scholar
• Duplantier AJ, Turner CR. Novel pharmacological approaches to the treatment of asthma: status and potential of therapeutic classes. Drug Discov Today 1996;1(5):199-208
   Web of Science ®Google Scholar
• Arch JR, Bowring NE, Buckle DR. Evaluation of the novel potassium channel activator BRL 55834 as an inhaled bronchodilator in guinea-pigs and rats: comparison with levcromakalim and salbutamol. Pulm Pharmacol 1994;7(2):121-8
   PubMedGoogle Scholar
• Ishizawa T, Koga H, Sato H, et al. Substitutent effects of benzopyran-4-(N-cyano)-carboxamide potassium channel openers for selectivity to guinea pig trachealis. Bioorg Med Chem Lett 1994;4(16):1995-8
   Google Scholar
• Koga H, Sato H, Ishizawa T, et al. N,N-disubstituted benzopyran-4-(N´-cyano)-carboxamidines, cromakalim analogs with selective activity for guinea trachealis. Bioorg Med Chem Lett 1993;3(6):1111-4
   Google Scholar
• Chapman ID, Mazzoni L, Morley J. Actions of SDZ PCO 400 and cromakalim on airway smooth muscle in vivo Agents and Actions 1991;34:53-62
   PubMedGoogle Scholar
• Chapman ID, Kristersson A, Mathelin G, et al. Effects of a potassium channel opener (SDZ PCO 400) on guinea-pig and human pulmonary airways. Br J Pharmacol 1992;106(2):423-9
   PubMed Web of Science ®Google Scholar
• Small RC, Berry JL, Foster RW, et al. Analysis of the relaxant action of SDZ PCO 400 in airway smooth muscle from the ox and guinea-pig. Eur J Pharmacol 1992;219(1):81-8
   PubMedGoogle Scholar
• Sandoz A.-G.: GB2204868; 1988
   Google Scholar
• El-Hashim AZ, Buchheit KH, Fozard J, et al. Effect of the K+(ATP) channel opener, KCO912, on baseline and allergen induced airway hyperresponsiveness in allergic rabbits. Eur J Pharmacol 2004;484(2-3):351-6
   PubMed Web of Science ®Google Scholar
• Buchheit KH, Manley PW, Quast U, et al. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects. Naunyn-Schmiedeberg's Arch Pharmacol 2002;365(3):220-30
   Google Scholar
• Imagawa J, Yoshida S, Koga T, et al. The effect of a novel benzopyran derivative, KC 399, on the isolated guinea-pig trachealis and human bronchi. Gen pharmacol 1993;24(6):1505-12
   PubMedGoogle Scholar
• Kamei K, Nabata H, Kuriyama H. Effects of KC 399, a novel ATP-sensitive K+ channel opener, on electrical and mechanical responses in dog tracheal smooth muscle. J Pharmacol Exp Ther 1994;268(1):319-27
   PubMedGoogle Scholar
• Imagawa J, Kamei K, Yoshida S, et al. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig. J Pharmacol Exp Ther 1994;269(1):1-6
   PubMedGoogle Scholar
• Kamei K, Nabata H, Kuriyama H, et al. Effect of KC399, a newly synthesized K+ channel opener, on acetylcholine-induced electrical and mechanical activities in rabbit tracheal smooth muscle. Br J Pharmacol 1995;115(8):1493-501
   PubMedGoogle Scholar
• Perez-Vizcaino F, Casis O, Rodriguez R, et al. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle. Br J Pharmacol 1993;110(3):1165-71
   PubMedGoogle Scholar
• Almansa C, Gomez LA, Cavalcanti FL, et al. 2,2-Dialkylnaphthalen-1-ones as new potassium channel activators. J Med Chem 1993;36(15):2121-33
   PubMed Web of Science ®Google Scholar
• Englert HC, Wirth K, Gehring D, et al. Airway pharmacology of the potassium channel opener, HOE 234, in guinea pigs: in vitro and in vivo studies. Eur J Pharmacol 1992;210(1):69-75
   PubMedGoogle Scholar
• Miura M, Belvisi MG, Ward JK, et al. Bronchodilating effects of the novel potassium channel opener HOE 234 in human airways in vitro Br J Clin Pharmacol 1993;35(3):318-20
   PubMed Web of Science ®Google Scholar
• Kidney JC, Lotvall JO, Lei Y, et al. The effect of inhaled K+ channel openers on bronchoconstriction and airway microvascular leakage in anaesthetised guinea pigs. Eur J Pharmacol 1996;296(1):81-7
   PubMedGoogle Scholar
• Redemann B, Vaali K, Li L, et al. Effects of potassium-channel opener HOE 234 in guinea-pig airways. J Pharm Pharmacol 1996;48(6):619-23
   PubMedGoogle Scholar
• Ishikawa J, Saitoh C, Masaki K, et al. Effect of YM934, a novel potassium-channel opener, in various experimental asthma models in guinea-pigs. J Pharm Pharmacol 1996;48(10):1034-40
   PubMedGoogle Scholar
• Paciorek PM, Cowlrick IS, Perkins RS, et al. Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig. Br J Pharmacol 1990;100(2):289-94
   PubMedGoogle Scholar
• Mannhold R. KATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev 2004;24(2):213-66
   PubMed Web of Science ®Google Scholar
• Mannhold R, Leclerc G. Second-generation K(ATP) channel openers. Mini Rev Med Chem 2005;5(11):961-9
   PubMedGoogle Scholar
• Sebille S, De Tullio P, Boverie S, et al. Recent developments in the chemistry of potassium channel activators: the cromakalim analogs. Curr Med Chem 2004;11(9):1213-22
   PubMed Web of Science ®Google Scholar
• Cecchetti V, Tabarrini O, Sabatini S. From cromakalim to different structural classes of K(ATP) channel openers. Curr Top Med Chem 2006;6(10):1049-68
   PubMedGoogle Scholar
• Breschi MC, Calderone V, Martelli A, et al. New benzopyran-based openers of the mitochondrial ATP-sensitive potassium channel with potent anti-ischemic properties. J Med Chem 2006;49(26):7600-2
   PubMedGoogle Scholar
• Sebille S, Gall D, de Tullio P, et al. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim. J Med Chem 2006;49(15):4690-7
   PubMedGoogle Scholar
• Khelili S, Lebrun P, de Tullio P, et al. Synthesis and pharmacological evaluation of some N-arylsulfonyl-N-methyl-N′- (2,2-dimethyl-2H-1-benzopyran-4-yl)ureas structurally related to cromakalim. Bioorg Med Chem 2006;14(10):3530-34
   PubMedGoogle Scholar
• Cosgrove KE, Straub SG, Barnes PD, et al. Y-26763: ATP-sensitive K+ channel activation and the inhibition of insulin release from human pancreatic beta-cells. Eur J Pharmacol 2004;486(2):133-9
   PubMedGoogle Scholar
• Lee JH, Jung IS, Lee SH, et al. Cardioprotective effects of BMS-180448, a prototype mitoK(ATP) channel opener, and the role of salvage kinases, in the rat model of global ischemia and reperfusion heart injury. Arch Pharm Res 2007;30(5):634-40
   PubMedGoogle Scholar
• Individual. US20070049556; 2007
   Google Scholar
• Janssen Pharmaceutica. WO2007027780; 2007
   Google Scholar
• Individual. US20050182065; 2005
   Google Scholar
• Janssen Pharmaceutica. WO2006078833; 2006
   Google Scholar
• Janssen Pharmaceutica. WO2006091769; 2006
   Google Scholar
• Janssen Pharmaceutica. WO2006091800; 2006
   Google Scholar
• Stretton D, Miura M, Belvisi MG, et al. Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proceedings of the National Academy of Sciences of the United States of America. 1992;89(4):1325-9
   Google Scholar
• Miura M, Belvisi MG, Stretton CD, et al. Role of K+ channels in the modulation of cholinergic neural responses in guinea-pig and human airways. J Physiol 1992;455:1-15
   PubMed Web of Science ®Google Scholar
• Joos GF, Pauwels RA. Tachykinin receptor antagonists: potential in airways diseases. Curr Opin Pharmacol 2001;1(3):235-41
   PubMedGoogle Scholar
• Nardi A, Olesen SP. BK channel modulators: a comprehensive overview. Curr Med Chem 2008;15(11):1126-46
   PubMedGoogle Scholar
• Belvisi MG. Preclinical assessment of novel therapeutics on the cough reflex: cannabinoid agonists as potential antitussives. Lung 2008;180(Suppl. 1):566-9
   PubMedGoogle Scholar
• Yoshihara S, Morimoto H, Yamada Y, et al. Cannabinoid receptor agonists inhibit sensory nerve activation in guinea pig airways. Am J Respire Crit Care Med 2004;170(9):941-6
   PubMedGoogle Scholar
• Yoshihara S, Morimoto H, Ohori M, et al. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways. Int Arch Allergy Immunol 2005;138(1):80-7
   PubMedGoogle Scholar
• NeuroSearch A/S: WO2007104719; 2007
   Google Scholar
• Barnes PJ. The problem of cough and development of novel antitussives. Pulm Pharmacol Ther 2007;20(4):416-22
   PubMedGoogle Scholar
• Rogers DF. Pharmacological regulation of the neuronal control of airway mucus secretion. Curr Opin Pharmacol 2002;2(3):249-55
   PubMed Web of Science ®Google Scholar
• Spina D, Shah S, Harrison S. Modulation of sensory nerve function in the airways. Trends Pharmacol Sci 1998;19(11):460-6
   PubMed Web of Science ®Google Scholar
• Miura M, Belvisi MG, Barnes PJ. Effect of bradykinin on airway neural responses in vitro J Appl Physiol 1992;73(4):1537-41
   PubMedGoogle Scholar
• Jones TR, Charette L, Garcia ML, et al. Interaction of iberiotoxin with beta-adrenoceptor agonists and sodium nitroprusside on guinea pig trachea. J Appl Physiol 1993;74(4):1879-84
   PubMed Web of Science ®Google Scholar
• Kume H, Hall IP, Washabau RJ, et al. Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J Clin Invest 1994;93(1):371-9
   PubMed Web of Science ®Google Scholar
• Ise S, Nishimura J, Hirano K, et al. Theophylline attenuates Ca2+ sensitivity and modulates BK channels in porcine tracheal smooth muscle. Br J Pharmacol 2003;140(5):939-47
   PubMedGoogle Scholar
• Suarez-Kurtz G, Garcia ML, Kaczorowski GJ. Effects of charybdotoxin and iberiotoxin on the spontaneous motility and tonus of different guinea pig smooth muscle tissues. J Pharmacol Exp Ther 1991;259(1):439-43
   PubMedGoogle Scholar
• Isaac L, McArdle S, Miller NM, et al. Effects of some K(+)-channel inhibitors on the electrical behaviour of guinea-pig isolated trachealis and on its responses to spasmogenic drugs. Br J Pharmacol 1996;117(8):1653-62
   PubMedGoogle Scholar
• Semenov I, Wang B, Herlihy JT, et al. channel beta1-subunit regulation of calcium handling and constriction in tracheal smooth muscle. Am J Physiol 2006;291(4):L802-10
   PubMedGoogle Scholar
• Brenner R, Perez GJ, Bonev AD, et al. Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 2000;407(6806):870-6
   PubMed Web of Science ®Google Scholar
• Petkov GV, Bonev AD, Heppner TJ, et al. Beta1-subunit of the Ca2+-activated K+ channel regulates contractile activity of mouse urinary bladder smooth muscle. J Physiol 2001;537(Pt 2):443-52
   PubMed Web of Science ®Google Scholar
• Hagen BM, Bayguinov O, Sanders KM. Beta 1-subunits are required for regulation of coupling between Ca2+ transients and Ca2+-activated K+ (BK) channels by protein kinase C. Am J Physiol Cell Physiol 2003;285(5):C1270-80
   PubMed Web of Science ®Google Scholar
• McManus OB, Harris GH, Giangiacomo KM, et al. An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 1993;32(24):6128-33
   PubMed Web of Science ®Google Scholar
• Lee SH, Hensens OD, Helms GL, et al. L-735,334, a novel sesquiterpenoid potassium channel-agonist from Trichoderma virens. J Nat Prod 1995;58(12):1822-8
   PubMedGoogle Scholar
• Singh S, Goetz, MA, Zink, DL, et al. J Chem Soc Perkin Trans 1994;1:3349-52
   Google Scholar
• Homma M, Oka K, Kobayashi H, et al. Impact of free magnolol excretions in asthmatic patients who responded well to saiboku-to, a Chinese herbal medicine. J Pharm Pharmacol 1993;45(9):844-6
   PubMed Web of Science ®Google Scholar
• Wu SN, Chen CC, Li HF, Lo YK, et al. Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol. Thorax 2002;57(1):67-74
   PubMedGoogle Scholar
• Bonnet PA, Michel A, Laurent F, et al. Synthesis and antibronchospastic activity of 8-alkoxy- and 8-(alkylamino)imidazo[1,2-a]pyrazines. J Med Chem 1992;35(18):3353-8
   PubMedGoogle Scholar
• Buchheit KH, Hofmann A, Pfannkuche HJ. In vitro and in vivo effects of SCA40 on guinea pig airways. Naunyn-Schmiedeberg's Arch Pharmacol 1997;355(2):217-23
   Google Scholar
• Macmillan S, Sheridan RD, Chilvers ER, et al. A comparison of the effects of SCA40, NS 004 and NS 1619 on large conductance Ca(2+)-activated K+ channels in bovine tracheal smooth muscle cells in culture. Br J Pharmacol 1995;116(1):1656-60
   PubMedGoogle Scholar
• Gribkoff VK, Lum-Ragan JT, Boissard CG, et al. Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol Pharmacol 1996;50(1):206-17
   PubMed Web of Science ®Google Scholar
• Dimitropoulou C, White RE, Ownby DR, et al. Estrogen reduces carbachol-induced constriction of asthmatic airways by stimulating large-conductance voltage and calcium-dependent potassium channels. Am J Respir Cell Mol Boil 2005;32(3):239-47
   PubMed Web of Science ®Google Scholar
• Brief, non-confidential profile of Andolast from Rottapharm [cited 01 July 2008]; Available from: http://www.rotta.com/pages/canali/r&d/profili/2039.asp
   Google Scholar
• Makovec F, Peris W, Revel L, et al. Antiallergic and cytoprotective activity of new N-phenylbenzamido acid derivatives. J Med Chem 1992;35(20):3633-40
   PubMedGoogle Scholar
• Rotta Research Laboratorium. WO9009989; 1990
   Google Scholar
• Revel L, Colombo S, Ferrari F, et al. CR 2039, a new bis-(1H-tetrazol-5-yl)phenylbenzamide derivative with potential for the topical treatment of asthma. Eur J Pharmacol 1992;229(1):45-53
   PubMedGoogle Scholar
• Persiani S, D'Amato M, Makovec F, et al. Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients. Biopharm Drug Dispos 2001;22(2):73-81
   PubMedGoogle Scholar
• Rottapharm: EP1634595; 2007
   Google Scholar
• Rotta Research Laboratorium. EP00896821; 1999
   Google Scholar
• Boehringer Ingelheim. WO2007077164; 2007
   Google Scholar
• Sepracor, Inc. WO2005123071; 2005
   Google Scholar
• Sepracor, Inc. WO2005123072; 2005
   Google Scholar
• Rottapharm. WO2008014814; 2008
   Google Scholar
• Lawson K, Barras M, Armstrong JM, Hicks PE. Effects of K+ channel inhibitors and antagonists on NS-004 evoked relaxations in guinea-pig isolated trachea. Fundam Clin Pharmacol 1997;11(1):78-82
   PubMedGoogle Scholar
• NeuroSearch A/S. WO2004002962 or US7244756; 2004
   Google Scholar
• NeuroSearch A/S. WO2008074755; 2008
   Google Scholar
• NeuroSearch A/S. WO2008074756; 2008
   Google Scholar
• Nardi A, Olesen SP. Acrylamides as potassium channel openers. Exp Opin Ther Patents 2007;17(10):1215-26
   Web of Science ®Google Scholar
• Bentzen BH, Nardi A, Calloe K, et al. The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels. Mol Pharmacol 2007;72(4):1033-44
   PubMed Web of Science ®Google Scholar
• Li L, Vaali K, Vapaatalo H, et al. Effects of K(+) channel inhibitors on relaxation induced by flufenamic and tolfenamic acids in guinea-pig trachea. Eur J Pharmacol 1999;383(2):169-76
   PubMedGoogle Scholar
• Li L, Vapaatalo H, Vaali K, et al. Flufenamic and tolfenamic acids and lemakalim relax guinea-pig isolated trachea by different mechanisms. Life Sci 1998;62(20):PL303-8
   Google Scholar
• Bristol-Myers Squibb Company. WO2004058260; 2004
   Google Scholar
• Tanabe Seyaku. WO2004035570; 2004
   Google Scholar
• Thompson-Vest N, Shimizu Y, Hunne B, et al. The distribution of intermediate-conductance, calcium-activated, potassium (IK) channels in epithelial cells. J Anat 2006;208(2):219-29
   PubMedGoogle Scholar
• Wulff H, Kolski-Andreaco A, Sankaranarayanan A, et al. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 2007;14(13):1437-57
   PubMed Web of Science ®Google Scholar
• Brugnara C, Gee B, Armsby CC, et al. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest 1996;97(5):1227-34
   PubMed Web of Science ®Google Scholar
• Brugnara C, de Franceschi L. [Clinical trials of new therapeutic pharmacology for sickle cell disease]. Sante (Montrouge, France) 2006;16(4):263-8
   Google Scholar
• Wulff H, Gutman GA, Cahalan MD, et al. Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem 2001;276(34):32040-5
   PubMedGoogle Scholar
• Press release from Icagen website [cited 01 July 2008]; Available from: http://ir.icagen.com/phoenix.zhtml?c=178443&p=irol-newsArticle&ID=981557&highlight=
   Google Scholar
• Parihar AS, Coghlan MJ, Gopalakrishnan M, et al. Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 2003;471(3):157-64
   PubMed Web of Science ®Google Scholar
• Jager H, Dreker T, Buck A, et al. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro Mol Pharmacol 2004;65(3):630-8
   PubMedGoogle Scholar
• Wang ZH, Shen B, Yao HL, et al. Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer. Oncogene 2007;26(35):5107-14
   PubMed Web of Science ®Google Scholar
• Benzaquen LR, Brugnara C, Byers HR, et al. Clotrimazole inhibits cell proliferation in vitro and in vivo Nat Med 1995;1(6):534-40
   PubMed Web of Science ®Google Scholar
• Kohler R, Wulff H, Eichler I, et al. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003;108(9):1119-25
   PubMed Web of Science ®Google Scholar
• Pena TL, Chen SH, Konieczny SF, et al. Ras/MEK/ERK Up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis. J Biol Chem 2000;275(18):13677-82
   PubMedGoogle Scholar
• Neylon CB. Potassium channels and vascular proliferation. Vasc Pharmacol 2002;38(1):35-41
   PubMedGoogle Scholar
• Tharp DL, Wamhoff BR, Turk JR, et al. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006;291(5):H2493-503
   Google Scholar
• Panyi G, Possani LD, Rodriguez de la Vega RC, et al. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr Pharm Des 2006;12(18):2199-220
   PubMedGoogle Scholar
• Rufo PA, Merlin D, Riegler M, et al. The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera. J Clin Invest 1997;100(12):3111-20
   PubMedGoogle Scholar
• Beth Israel Deaconess Medical Center, Children's Medical Center Corporation: US5889038; 2002
   Google Scholar
• Cowley EA, Linsdell P. Oxidant stress stimulates anion secretion from the human airway epithelial cell line Calu-3: implications for cystic fibrosis lung disease. J Physiol 2002;543(Pt 1):201-9
   PubMed Web of Science ®Google Scholar
• Berkowitz LR, Orringer EP. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability. J Clin Invest 1981;68(5):1215-20
   PubMedGoogle Scholar
• Benton DC, Roxburgh CJ, Ganellin CR, et al. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells. Br J Pharmacol 1999;126(1):169-78
   PubMed Web of Science ®Google Scholar
• Roxburgh CJ, Ganellin CR, Athmani S, et al. Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes. J Med Chem 2001;44(20):3244-53
   PubMedGoogle Scholar
• Narenjkar J, Assem el SK, Ganellin CR. Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues. Eur J Pharmacol 2004;483(2-3):107-16
   PubMedGoogle Scholar
• Alvarez J, Montero M, Garcia-Sancho J. High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors. J Biol Chem 1992;267(17):11789-93
   PubMed Web of Science ®Google Scholar
• Kaji DM. Nifedipine inhibits calcium-activated K transport in human erythrocytes. Am J Physiol 1990;259(2 Pt 1):C332-9
   Google Scholar
• Urbahns K, Horvath E, Stasch JP, et al. 4-Phenyl-4H-pyrans as IK(Ca) channel blockers. Bioorg Med Chem Lett 2003;13(16):2637-9
   PubMedGoogle Scholar
• Bayer A.-G. EP758648; 1997
   Google Scholar
• NeuroSearch A/S. WO2003059873; 2003
   Google Scholar
• Individual. WO2006096911; 2006
   Google Scholar
• NeuroSearch A/S. WO2005003094; 2005
   Google Scholar
• NeuroSearch A/S. WO2005003143; 2005
   Google Scholar
• Icagen. WO2004016221; 2004
   Google Scholar
• Children's Medical Center Corporation. WO9926624; 1999
   Google Scholar
• Children's Medical Center Corporation, Ion Pharmaceuticals. WO9926611; 1999
   Google Scholar
• Children's Medical Center Corporation, Ion Pharmaceuticals: WO9926628; 1999
   Google Scholar
• Children's Medical Center Corporation, Ion Pharmaceuticals. WO9926929; 1999
   Google Scholar
• Press release from Icagen website. [cited 01 July 2008]; Available from: http://ir.icagen.com/phoenix.zhtml?c=178443&p=irol-newsArticle&ID=1093375&highlight=
   Google Scholar
• Children's Medical Center Corporation. WO9734589; 1997
   Google Scholar
• Icagen. WO2000050026; 2000
   Google Scholar
• McNaughton-Smith GA, Burns JF, Stocker JW, et al. Novel inhibitors of the Gardos channel for the treatment of sickle cell disease. J Med Chem 2008;51(4):976-82
   PubMed Web of Science ®Google Scholar
• Seibold MA, Wang B, Eng C, et al. An African-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. Hum Mol Genet 2008;17(17):2681-90
   PubMedGoogle Scholar
• Zhou XB, Wulfsen I, Lutz S, et al. M2muscarinic receptors induce airway smooth muscle activation via a dual,Gbeta gamma mediated inhibition of BK channel activity. J Biol Chem 2008;283:21036-44
   PubMed Web of Science ®Google Scholar
• Morin C, Sirois M, Echave V, et al. Functional effects of 20-HETE on human bronchi: hyperpolarization and relaxation due to BKCa channel activation. Am J Physiol 2007;293(4):L1037-44
   Web of Science ®Google Scholar